Literature DB >> 20691710

Epigenomics of human colon cancer.

F Javier Carmona1, Manel Esteller.   

Abstract

DNA methylation exerts critical effects on gene-expression regulation in normal cells, and alterations on the normal methylation patterns characterize, and likely contribute, to cancer development and progression. The complete understanding of the distinctiveness, role and dynamics of the cancer cell epigenome has been hindered so far by technical limitations, and new, whole-genome approaches are required. Here we review the methods that have permitted us glimpses of the colon cancer methylome and outline future directions that will eventually lead researchers to identify the altered epigenetic patterns in cancer cells. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20691710     DOI: 10.1016/j.mrfmmm.2010.07.007

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  26 in total

1.  Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma.

Authors:  Christina Michailidi; Stamatios Theocharis; Gerasimos Tsourouflis; Vasiliki Pletsa; Gregorios Kouraklis; Efstratios Patsouris; Athanasios G Papavassiliou; Constantinos Troungos
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-23

2.  Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation.

Authors:  Qiong Yang; Ying Dong; Wei Wu; Chunlei Zhu; Hui Chong; Jiangyang Lu; Dehai Yu; Libing Liu; Fengting Lv; Shu Wang
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 3.  The value of epigenetic markers in esophageal cancer.

Authors:  Xiao-Mei Zhang; Ming-Zhou Guo
Journal:  Front Med China       Date:  2010-11-24

Review 4.  Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.

Authors:  María Antonia Lizarbe; Jorge Calle-Espinosa; Eva Fernández-Lizarbe; Sara Fernández-Lizarbe; Miguel Ángel Robles; Nieves Olmo; Javier Turnay
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

5.  Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon-rectum.

Authors:  Daniela Furlan; Nora Sahnane; Mara Mazzoni; Roberta Pastorino; Ileana Carnevali; Michele Stefanoli; Andrea Ferretti; Anna Maria Chiaravalli; Stefano La Rosa; Carlo Capella
Journal:  Virchows Arch       Date:  2012-12-09       Impact factor: 4.064

Review 6.  Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer.

Authors:  Scott J Bultman
Journal:  Mol Nutr Food Res       Date:  2016-06-02       Impact factor: 5.914

7.  Leukocyte DNA methylation and colorectal cancer among male smokers.

Authors:  Ying Gao; Keith Killian; Hong Zhang; Kai Yu; Qi-Zhai Li; Stephanie Weinstein; Jarmo Virtamo; Margaret Tucker; Philip Taylor; Demetrius Albanes; Paul Meltzer; Neil Caporaso
Journal:  World J Gastrointest Oncol       Date:  2012-08-15

Review 8.  Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.

Authors:  André Nogueira da Costa; Zdenko Herceg
Journal:  Mol Oncol       Date:  2012-08-16       Impact factor: 6.603

Review 9.  Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary.

Authors:  Sebastián Moran; Anna Martinez-Cardús; Stergios Boussios; Manel Esteller
Journal:  Nat Rev Clin Oncol       Date:  2017-07-04       Impact factor: 66.675

10.  KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer.

Authors:  Patricia Moya; Sergio Esteban; Antonio Fernandez-Suarez; Marisa Maestro; Manuel Morente; Marta Sánchez-Carbayo
Journal:  Tumour Biol       Date:  2012-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.